CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice

Thrombosis and Haemostasis

Volumn 110, Issue 6, 2013, Pages 1267-1277

  Manthey, Helga D ^a   Cochain, Clément ^b   Barnsteiner, Stefanie ^a   Karshovska, Ela ^c   Pelisek, Jaroslav ^b   Koch, Miriam ^a   Chaudhari, Sweena M ^a,b   Busch, Martin ^a   Eckstein, Hans Henning ^b,d   Weber, Christian ^c,d   Koenen, Rory R ^c   Zernecke, Alma ^b,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atherosclerosis; CCR6; Chemokines; Monocyte; Recruitment

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MALE; MICROSCOPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ATHEROSCLEROSIS; CCR6; CHEMOKINES; MONOCYTE; RECRUITMENT;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; RECEPTORS, CCR6; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; T-LYMPHOCYTES;

EID: 84888396301     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-01-0017     Document Type: Article

References (31)

1. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature reviews Immunology 2008; 8: 802-815.
2. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410-1422.
3. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-692.
4. Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194.
5. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolaemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117: 195-205.
6. Soehnlein O, Drechsler M, Doring Y, et al. Distinct functions of chemokine receptor axes in the atherogenic mobilisation and recruitment of classical monocytes. EMBO Mol Med 2013; 5: 471-481.
7. Combadiere C, Potteaux S, Rodero M, et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolaemic mice. Circulation 2008; 117: 1649-1657.
8. Zernecke A, Weber C. Chemokines in the vascular inflammatory response of atherosclerosis. Cardiovasc Res 2010; 86: 192-201.
9. Ley K, Laudanna C, Cybulsky MI, et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007; 7: 678-689.
10. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27: 165-197.
11. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
12. Taleb S, Tedgui A, Mallat Z. Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol 2010; 10: 197-202.
13. Taleb S, Tedgui A, Mallat Z. Interleukin-17: friend or foe in atherosclerosis? Current Opin Lipidol 2010; 21: 404-408.
14. Yilmaz A, Lipfert B, Cicha I, et al. Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques. Exp Mol Pathol 2007; 82: 245-255.
15. Wan W, Lim JK, Lionakis MS, et al. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice. Circ Res 2011; 109: 374-381.
16. Calvayrac O, Rodriguez-Calvo R, Alonso J, et al. CCL20 is increased in hypercholesterolaemic subjects and is upregulated by LDL in vascular smooth muscle cells: role of NF-kappaB. Arterioscler Thromb Vasc Biol 2011; 31: 2733-2741.
17. Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517.
18. Yamazaki T, Yang XO, Chung Y, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. J Immunol 2008; 181: 8391-8401.
19. Robbins CS, Chudnovskiy A, Rauch PJ, et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012; 125: 364-374.
20. Meissner A, Zilles O, Varona R, et al. CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 2003; 102: 2724-2727.
21. Wan W, Murphy PM. Regulation of atherogenesis by chemokine receptor CCR6. Trends Cardiovasc Med 2011; 21: 140-144.
22. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006; 7: 311-317.
23. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-616.
24. Landsman L, Bar-On L, Zernecke A, et al. CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009; 113: 963-972.
25. Wen H, Hogaboam CM, Lukacs NW, et al. The chemokine receptor CCR6 is an important component of the innate immune response. Eur J Immunol 2007; 37: 2487-2498.
26. Lortat-Jacob H. The molecular basis and functional implications of chemokine interactions with heparan sulphate. Curr Opin Struct Biol 2009; 19: 543-548.
27. Lortat-Jacob H, Grosdidier A, Imberty A. Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA 2002; 99: 1229-1234.
28. Shantsila E, Devitt A, Lip GY. Circulating monocytes and atherogenesis: from animal experiments to human studies. Thromb Haemost 2010; 104: 191-193.
29. Rogacev KS, Cremers B, Zawada AM, et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012; 60: 1512-1520.
30. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011; 106: 757-762.
31. Cros J, Cagnard N, Woollard K, et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33: 375-386.